These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33884654)

  • 101. Expanded natural killer cells augment the antimyeloma effect of daratumumab, bortezomib, and dexamethasone in a mouse model.
    Thangaraj JL; Ahn SY; Jung SH; Vo MC; Chu TH; Thi Phan MT; Kwon M; Lee KH; Kim M; Song GY; Yang DH; Ahn JS; Kim HJ; Cho D; Lee JJ
    Cell Mol Immunol; 2021 Jul; 18(7):1652-1661. PubMed ID: 33980993
    [TBL] [Abstract][Full Text] [Related]  

  • 102. A novel severity scoring system for murine ocular graft versus host disease and its correlation with CD3
    Guasch FM; Sajjan S; Tibbs E; Reandeau C; Wu L; Bohlen J; Li A; Plotkin A; Cao X; Sunshine SB
    Ocul Surf; 2024 Jul; 33():77-79. PubMed ID: 38823677
    [No Abstract]   [Full Text] [Related]  

  • 103. A Species-Specific Anti-Human P2X7 Monoclonal Antibody Reduces Graft-versus-Host Disease in Humanised Mice.
    Elhage A; Cuthbertson P; Sligar C; Watson D; Sluyter R
    Pharmaceutics; 2023 Aug; 15(9):. PubMed ID: 37765233
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Enhancement of natural killer cell activity by oral administration of a fermented soybean product in dogs.
    Mikawa S; Matsuda A; Kamemori Y; Asanuma S; Kitagawa H
    Open Vet J; 2021; 11(3):394-400. PubMed ID: 34722202
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Comparison of Phenotypic and Functional Characteristics Between Canine Non-B, Non-T Natural Killer Lymphocytes and CD3
    Lee SH; Shin DJ; Kim Y; Kim CJ; Lee JJ; Yoon MS; Uong TNT; Yu D; Jung JY; Cho D; Jung BG; Kim SK; Suh GH
    Front Immunol; 2018; 9():841. PubMed ID: 29755462
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Role of Natural Killer Cells in Intravenous Immunoglobulin-Induced Graft-versus-Host Disease Inhibition in NOD/LtSz-scidIL2rg(-/-) (NSG) Mice.
    Gregoire-Gauthier J; Fontaine F; Benchimol L; Nicoletti S; Selleri S; Dieng MM; Haddad E
    Biol Blood Marrow Transplant; 2015 May; 21(5):821-8. PubMed ID: 25596424
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Acute graft-versus-host-like disease induced by transplantation of human activated natural killer cells into SCID mice.
    Xun C; Brown SA; Jennings CD; Henslee-Downey PJ; Thompson JS
    Transplantation; 1993 Aug; 56(2):409-17. PubMed ID: 8356598
    [TBL] [Abstract][Full Text] [Related]  

  • 108. The effect of human IL-2-activated natural killer and T cells on graft-versus-host disease and graft-versus-leukemia in SCID mice bearing human leukemic cells.
    Xun CQ; Thompson JS; Jennings CD; Brown SA
    Transplantation; 1995 Oct; 60(8):821-7. PubMed ID: 7482742
    [TBL] [Abstract][Full Text] [Related]  

  • 109. How important is NK alloreactivity and KIR in allogeneic transplantation?
    Shaffer BC; Hsu KC
    Best Pract Res Clin Haematol; 2016 Dec; 29(4):351-358. PubMed ID: 27890259
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Cytokine-induced killer cells: NK-like T cells with cytotolytic specificity against leukemia.
    Linn YC; Hui KM
    Leuk Lymphoma; 2003 Sep; 44(9):1457-62. PubMed ID: 14565644
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Natural Killer and T Cell Infiltration in Canine Osteosarcoma: Clinical Implications and Translational Relevance.
    Razmara AM; Judge SJ; Gingrich AA; Cruz SM; Culp WTN; Kent MS; Rebhun RB; Canter RJ
    Front Vet Sci; 2021; 8():771737. PubMed ID: 34869744
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Safety analysis of ex vivo-expanded canine natural killer cells in a xenogeneic mouse model of graft-versus-host disease.
    Kim CJ; Park SC; Lee SH; Lim YJ; Yoon M; Park JG; Baek YB; Cho KO; Hong JW; Shin DJ; Kim SK
    J Leukoc Biol; 2022 Feb; 111(2):439-450. PubMed ID: 33884654
    [TBL] [Abstract][Full Text] [Related]  

  • 113.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 114.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 115.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 116.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 117.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.